Mercados españoles cerrados en 1 hr 51 mins

Sanofi (SNY)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
50,54-0,23 (-0,45%)
A partir del 9:39AM EDT. Mercado abierto.

Sanofi

54, Rue La BoEtie
Paris 75008
France
33 1 53 77 40 00
http://www.sanofi.com

Sector(es)Healthcare
SectorDrug Manufacturers—General
Empleados a tiempo completo99.412

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Paul HudsonCEO & Director6,7MN/A1967
Mr. Jean-Baptiste Chasseloup de ChatillonExec. VP & CFON/AN/A1965
Mr. Laurent GilhodesPrincipal Accounting Officer and VP of Corp. AccountingN/AN/AN/A
Mr. Bruno MénardChief Information officerN/AN/AN/A
Dr. Josephine FubaraChief Science Officer of Consumer Health CareN/AN/AN/A
Mr. George Grofik C.F.A., CPA, CFAHead of Investor RelationsN/AN/AN/A
Ms. Karen LinehanExec. VP of Legal Affairs & Gen. CounselN/AN/A1959
Mr. Dante BeccariaGlobal Compliance Officer & VPN/AN/AN/A
Mr. Josep CatllaHead of CommunicationsN/AN/AN/A
Mr. Pierre ChancelSr. VP of Global Diabetes and Sr. VP of Global MarketingN/AN/A1957
Los importes son a partir de 31 de diciembre de 2020 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Gobierno corporativo

El ISS Governance QualityScore de Sanofi, a día 1 de abril de 2021, es 5. Las puntuaciones base son Auditoría: 3; Tablero: 5; Derechos de los accionistas: 4; Compensación: 7.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.